Head-to-head · Cost-Efficiency Index
Sumbare Wellness vs HealthOn
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Sumbare Wellness
Shoppers comfortable with a floor price that's only confirmed after a clinical review, rather than a locked-in rate.
Visit Sumbare WellnessHealthOn
Cost-first shoppers comparing HealthOn's monthly, quarterly, and 12-month compounded GLP-1 tiers side by side.
Visit HealthOnThe verdict
Sumbare Wellness takes it, leading the Cost-Efficiency Index 58 to 57. Sumbare Wellness is a telehealth GLP-1 and peptide-therapy provider advertising 'plans from $199/mo,' explicitly contingent on provider review rather than guaranteed at booking. HealthOn still earns a C — Cost-first shoppers comparing HealthOn's monthly, quarterly, and 12-month compounded GLP-1 tiers side by side.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Sumbare Wellness.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Sumbare Wellness | HealthOn |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 57/100 |
| Semaglutide / mo | $199/mo (compounded) | $189/mo (1.5 mg dose, compounded) |
| Tirzepatide / mo | $199/mo (compounded) | $295/mo (10 mg dose, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,268 |
| Tirzepatide / yr (modeled) | $2,388 | $3,540 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #292 | #297 |
Sumbare Wellness
58/100Where the value is
- Offers both semaglutide and tirzepatide plus a microdose program
- States clinical outcome averages (15% vs 20% body weight loss) on the pricing-adjacent page
- Claims 'no hidden fees' with pricing confirmed transparently after clinical review
The tradeoffs
- '$199/mo' is a floor, not a locked price -- actual cost is only confirmed after provider review
- No medical director or specific pharmacy partner named
HealthOn
57/100Where the value is
- Both compounded semaglutide ($189/mo) and tirzepatide ($295/mo) are priced on their own dedicated product pages, not gated behind an intake
- Quarterly and 12-month prepay options are disclosed with real dollar savings ($549/quarter and $837/quarter respectively)
- Independent third-party batch testing for potency, sterility, pH, and endotoxins is disclosed as a stated policy
The tradeoffs
- The site's sitewide 'Starting at $155/mo*' nav banner is not specific to either medication and requires a 12-month prepay commitment to actually reach — a shopper skimming only the banner will underestimate the real starting cost by $34-140/mo
- No named prescriber, medical director, or specific compounding pharmacy anywhere on the pages checked
Regulatory note: the FDA issued a warning letter to Healthon Inc. dba Healthon in September 2025. We still list and link to HealthOn; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.